Atlas Trials

Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers

Clinical trial NCT06282588 · RECRUITING

Trial details

NCT number
NCT06282588
Sponsor
Cancer Research Antwerp
Status
RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2023-12-13
Primary completion
2030-07-31
Enrollment
493

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.